MISSION: managed a pharmaceutical factory extension to double manufacturing capacity for a respiratory medical device, from 20 to 40 M units/year (65 people, €130M Capex).
ACTIONS: established program governance (organization structure, strategy, finances, schedule, deliverables, risks and mitigation plans) - Managed stakeholders (business / finances / engineering / quality) - Member of site leadership team.
Construction of 2 new production lines (formulation + medical device assembly/packing), a new fully automated warehouse and a new Quality Control laboratory.
Managed transition to business in order to deliver assets ready to manufacture commercial batches.
ACHIEVEMENTS: transfer to business completed for all assets (assembly/packing line in February 2017, Quality Control lab in March 2018, fully automated warehouse in April 2018, formulation line in December 2018).
Unilabs - Medical Biology laboratories, turnover €160M, 1300 employees
June 2012
to October 2014
Full-time
Paris
France
MISSION: manage the post M&A operational integration of 50 new biology diagnosis and pathology laboratories into a French existing network, ending to a total of 102 laboratories in 19 regions.
ACTIONS: Consolidated production into regional core labs while keeping proximity collecting centers and emergency hospital labs / optimized personnel and equipment / harmonized and standardized operations / Implemented lean solutions.
6 months acting as turnaround manager for the Champagne region.
ACHIEVEMENTS: built strong foundations in each regional labs to support further commercial development / Champagne region laboratories back on track in terms of organization, financial performance and quality of service / implemented €4.9M operational synergies in less than 2 years.
MISSION: built technical platforms and reorganized 3 majors medical supporting functions :
BIOLOGY: regrouped 23 medical diagnosis laboratories, biology and pathology, into one single 20.000 m² medical center building (800 people, 7000 analysis/day).
STERILIZATION: created with GCS Sterinord one of the most innovative sterilizing surgical instrument industrial platforms in France (90 people, 1000 surgical kits a day, 5 hospitals).
BLOOD TRANSFUSION: revamped the hospital blood histocompatibility and distribution processes for blood transfusion with Etablissement Français du Sang (60 people, 50.000 blood bags a year).
ACHIEVEMENTS: operational expenses decreased by €5M - improved drastically quality of service to clinicians by reducing turnaround time by half.
Gilson - Robotics and Lab Equipment, turnover $60M, 400 employees
March 2000
to February 2003
Full-time
Madison
United States - Wisconsin
Robotics Business Unit manager (turnover $16M, 30 people).
Developed and launched a new line of robots for biotech and pharmaceutical industries / coordinated engineering development between French and USA teams => $5M extra sales.
In 2002-2003, managed the consolidation of the business unit in one single location in US => decreased operating expenses by 15%.
French Atomic Energy Agency - Cis Bio International - Medical Diagnosis, turnover €35M, 200 employees
February 1997
to February 2000
Full-time
Saclay
France
Set up and managed customer service teams in 18 countries to support the launch of a medical diagnosis robot, with a strong focus in Asia with the creation of a hub in Japan to cover the Asia-Pacific region (60 people).
Packard Instrument - Medical Robotics, turnover $80M, 400 employees
February 1993
to January 1997
Full-time
Chicago
United States - Illinois
Managed the joint successful development of a medical diagnosis robot between a French company (Cis Bio International) and an American one (Packard) (25 people).
Managing cross-functional transformation projects and programs, change management and organization optimization in international environments (Europe, USA, Asia).
Strong focus on execution and getting things done, simplifying issues and driving for effective solutions to boost the development of the entire business and improve financial performance.